Exchange: NYSE Sector: Financial Services Industry: Asset Management
0.51% $40.04
America/New_York / 9 mai 2024 @ 13:10
FUNDAMENTALS | |
---|---|
MarketCap: | 503.21 mill |
EPS: | 1.440 |
P/E: | 27.81 |
Earnings Date: | N/A |
SharesOutstanding: | 12.57 mill |
Avg Daily Volume: | 0.0303 mill |
RATING 2024-05-09 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Sell | |
Return On Asset: | Strong Buy | |
DE: | Strong Sell | |
P/E: | Buy | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | n/a | n/a | n/a | |||
Debt | n/a |
PE RATIO: COMPANY / SECTOR |
---|
2.81x |
Company: PE 27.81 | sector: PE 9.91 |
PE RATIO: COMPANY / INDUSTRY |
---|
1.39x |
Company: PE 27.81 | industry: PE 20.04 |
DISCOUNTED CASH FLOW VALUE |
---|
$-0.268 (-100.67%) $-40.31 |
Date: 2024-05-09 |
Expected Trading Range (DAY) |
---|
$ 39.60 - 40.49 ( +/- 1.11%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-31 | Mcclements Kyle | Buy | 0 | |
2024-01-31 | Mcclements Kyle | Buy | 626 | Common Stock |
2024-01-31 | Mcclements Kyle | Sell | 626 | Common Stock |
2024-01-31 | Mcclements Kyle | Buy | 606 | Phantom Shares |
2024-01-31 | Mcclements Kyle | Sell | 266 | Phantom Shares |
INSIDER POWER |
---|
-9.87 |
Last 92 transactions |
Buy: 114 283 | Sell: 124 895 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $40.04 (0.51% ) |
Volume | 0.0083 mill |
Avg. Vol. | 0.0303 mill |
% of Avg. Vol | 27.32 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.